Marian C Neidert1, Michael T Lawton2, Marius Mader1, Burkhardt Seifert3, Antonios Valavanis4, Luca Regli1, Oliver Bozinov1, Jan-Karl Burkhardt5. 1. Department of Neurosurgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland. 2. Department of Neurosurgery, University of California San Francisco, San Francisco, California, USA. 3. Department of Biostatistics, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland. 4. Department of Neuroradiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. 5. Department of Neurosurgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Electronic address: Jan-karl.burkhardt@usz.ch.
Abstract
OBJECTIVE: To establish an arteriovenous malformation (AVM) grading score for patients with ruptured AVM and associated intracerebral hemorrhage (ICH) to predict clinical outcome. METHODS: Patient data from January 2006 to December 2013 with newly diagnosed ICH caused by ruptured AVM and a modified Rankin Scale (mRS) score <2 before ICH were included for this analysis. Clinical outcome was dichotomized in favorable (mRS score, 0-2) and unfavorable (mRS score, 3-6) to find predictors for outcome and to establish a new score based on the areas under the receiver-operating characteristic curves (AUROC) at 3 months, 1 year, and at last follow-up (mean, 31 months). RESULTS: A total of 67 patients (mean age, 41 years; 66% male) were analyzed including 39 patients with favorable and 28 with unfavorable outcome. Intraventricular hemorrhage (P = 0.048), ICH score (P = 0.003), AVM size (P < 0.001), Spetzler-Martin grade (P < 0.001), nidus structure (P = 0.005), Lawton-Young grade (P = 0.015), and supplemented Spetzler-Martin score (P < 0.001) were significant predictors for clinical outcome in ruptured AVMs. Based on these results, we created a new score named the AVICH (AVM-related ICH) score, which showed an AUROC of 0.842 compared to 0.789 for the supplemented Spetzler-Martin grading system and 0.703 for the ICH score regarding clinical outcome at last follow-up. CONCLUSIONS: Based on the AUROC analysis, the AVICH score predicts outcome of patients with ruptured AVM and associated ICH better than the ICH score, the Spetzler-Martin, or the supplemented Spetzler-Martin grading system. An external validation is needed before the AVICH score is tested in a prospective multicenter cohort.
OBJECTIVE: To establish an arteriovenous malformation (AVM) grading score for patients with ruptured AVM and associated intracerebral hemorrhage (ICH) to predict clinical outcome. METHODS:Patient data from January 2006 to December 2013 with newly diagnosed ICH caused by ruptured AVM and a modified Rankin Scale (mRS) score <2 before ICH were included for this analysis. Clinical outcome was dichotomized in favorable (mRS score, 0-2) and unfavorable (mRS score, 3-6) to find predictors for outcome and to establish a new score based on the areas under the receiver-operating characteristic curves (AUROC) at 3 months, 1 year, and at last follow-up (mean, 31 months). RESULTS: A total of 67 patients (mean age, 41 years; 66% male) were analyzed including 39 patients with favorable and 28 with unfavorable outcome. Intraventricular hemorrhage (P = 0.048), ICH score (P = 0.003), AVM size (P < 0.001), Spetzler-Martin grade (P < 0.001), nidus structure (P = 0.005), Lawton-Young grade (P = 0.015), and supplemented Spetzler-Martin score (P < 0.001) were significant predictors for clinical outcome in ruptured AVMs. Based on these results, we created a new score named the AVICH (AVM-related ICH) score, which showed an AUROC of 0.842 compared to 0.789 for the supplemented Spetzler-Martin grading system and 0.703 for the ICH score regarding clinical outcome at last follow-up. CONCLUSIONS: Based on the AUROC analysis, the AVICH score predicts outcome of patients with ruptured AVM and associated ICH better than the ICH score, the Spetzler-Martin, or the supplemented Spetzler-Martin grading system. An external validation is needed before the AVICH score is tested in a prospective multicenter cohort.
Authors: Tiago Gregório; Sara Pipa; Pedro Cavaleiro; Gabriel Atanásio; Inês Albuquerque; Paulo Castro Chaves; Luís Azevedo Journal: Neurocrit Care Date: 2019-04 Impact factor: 3.210
Authors: Vivek P Gupta; Andrew L A Garton; Jonathan A Sisti; Brandon R Christophe; Aaron S Lord; Ariane K Lewis; Hans-Peter Frey; Jan Claassen; E Sander Connolly Journal: World Neurosurg Date: 2017-02-27 Impact factor: 2.104
Authors: Ahmad Hafez; Päivi Koroknay-Pál; Elias Oulasvirta; Ahmed Abou Elseoud; Michael T Lawton; Mika Niemelä; Aki Laakso Journal: Neurosurgery Date: 2019-02-01 Impact factor: 4.654
Authors: Narlin B Beaty; Jessica K Campos; Geoffrey P Colby; Li-Mei Lin; Matthew T Bender; Risheng Xu; Alexander L Coon Journal: Interv Neurol Date: 2018-02-03
Authors: Tiago Gregório; Sara Pipa; Pedro Cavaleiro; Gabriel Atanásio; Inês Albuquerque; Paulo Castro Chaves; Luís Azevedo Journal: BMC Med Res Methodol Date: 2018-11-20 Impact factor: 4.615
Authors: Julia Velz; Martin Nikolaus Stienen; Marian Christoph Neidert; Yang Yang; Luca Regli; Oliver Bozinov Journal: Front Neurol Date: 2018-10-11 Impact factor: 4.003